UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Management of the Metabolic Syndrome and Type 2 Diabetes Through Lifestyle Modification

Annual review of nutrition, 2009-01, Vol.29 (1), p.223-256

2009

Volltextzugriff (PDF)

The role of falling leptin levels in the neuroendocrine and metabolic adaptation to short-term starvation in healthy men

The Journal of clinical investigation, 2003-05, Vol.111 (9), p.1409-1421

2003

Volltextzugriff (PDF)

Noninvasive predictors of clinically significant portal hypertension in NASH cirrhosis: Validation of ANTICIPATE models and development of a lab‐based model

Hepatology communications, 2022-12, Vol.6 (12), p.3324-3334

2022

Volltextzugriff (PDF)

The clinical approach to the detection of lipodystrophy - an AACE consensus statement

Endocrine practice, 2013-01, Vol.19 (1), p.107-116

2013

Volltextzugriff (PDF)

Differential regulation of metabolic, neuroendocrine, and immune function by leptin in humans

Proceedings of the National Academy of Sciences - PNAS, 2006-05, Vol.103 (22), p.8481-8486

2006

Volltextzugriff (PDF)

Randomised clinical trial: emricasan versus placebo significantly decreases ALT and caspase 3/7 activation in subjects with non‐alcoholic fatty liver disease

Alimentary pharmacology & therapeutics, 2019-01, Vol.49 (1), p.64-73

2019

Volltextzugriff (PDF)

Clinical effects of long-term metreleptin treatment in patients with lipodystrophy

Endocrine practice, 2011-11, Vol.17 (6), p.922-932

2011

Volltextzugriff (PDF)

Crinecerfont Lowers Elevated Hormone Markers in Adults With 21-Hydroxylase Deficiency Congenital Adrenal Hyperplasia

The journal of clinical endocrinology and metabolism, 2022-02, Vol.107 (3), p.801-812

2022

Volltextzugriff (PDF)

Crinecerfont, a CRF1 Receptor Antagonist, Lowers Adrenal Androgens in Adolescents With Congenital Adrenal Hyperplasia

The journal of clinical endocrinology and metabolism, 2023-10, Vol.108 (11), p.2871-2878

2023

Volltextzugriff (PDF)

Immunogenicity associated with metreleptin treatment in patients with obesity or lipodystrophy

Clinical endocrinology (Oxford), 2016-07, Vol.85 (1), p.137-149

2016

Volltextzugriff (PDF)

Recombinant Human Leptin in Women with Hypothalamic Amenorrhea

The New England journal of medicine, 2004-09, Vol.351 (10), p.987-997

2004

Volltextzugriff (PDF)

Phase 3 Trial of Crinecerfont in Adult Congenital Adrenal Hyperplasia

The New England journal of medicine, 2024-08, Vol.391 (6), p.504-514

2024

Volltextzugriff (PDF)

Phase 3 Trial of Crinecerfont in Pediatric Congenital Adrenal Hyperplasia

The New England journal of medicine, 2024-08, Vol.391 (6), p.493-503

2024

Volltextzugriff (PDF)

Multicenter, Double‐Blind, Randomized Trial of Emricasan in Hepatitis C–Treated Liver Transplant Recipients With Residual Fibrosis or Cirrhosis

Liver transplantation, 2021-04, Vol.27 (4), p.568-579

2021

Volltextzugriff (PDF)

Circulating Resistin Levels Are Not Associated with Obesity or Insulin Resistance in Humans and Are Not Regulated by Fasting or Leptin Administration: Cross-Sectional and Interventional Studies in Normal, Insulin-Resistant, and Diabetic Subjects

The journal of clinical endocrinology and metabolism, 2003-10, Vol.88 (10), p.4848-4856

2003

Volltextzugriff (PDF)

Serum Adiponectin Levels Are Inversely Associated with Overall and Central Fat Distribution but Are Not Directly Regulated by Acute Fasting or Leptin Administration in Humans: Cross-Sectional and Interventional Studies

The journal of clinical endocrinology and metabolism, 2003-10, Vol.88 (10), p.4823-4831

2003

Volltextzugriff (PDF)

Recombinant Methionyl Human Leptin Therapy in Replacement Doses Improves Insulin Resistance and Metabolic Profile in Patients with Lipoatrophy and Metabolic Syndrome Induced by the Highly Active Antiretroviral Therapy

The journal of clinical endocrinology and metabolism, 2006-07, Vol.91 (7), p.2605-2611

2006

Volltextzugriff (PDF)

Lymphoma in acquired generalized lipodystrophy

Leukemia & lymphoma, 2016-01, Vol.57 (1), p.45-50

2016

Volltextzugriff (PDF)

Clinical classification and treatment of congenital and acquired lipodystrophy

Endocrine practice, 2010-03, Vol.16 (2), p.310-323

2010

Volltextzugriff (PDF)

Diurnal and Ultradian Dynamics of Serum Adiponectin in Healthy Men: Comparison with Leptin, Circulating Soluble Leptin Receptor, and Cortisol Patterns

The journal of clinical endocrinology and metabolism, 2003-06, Vol.88 (6), p.2838-2843

2003

Volltextzugriff (PDF)

Rationale for leptin-replacement therapy for severe lipodystrophy

Endocrine practice, 2010-03, Vol.16 (2), p.324-333

2010

Volltextzugriff (PDF)

Regulation of circulating soluble leptin receptor levels by gender, adiposity, sex steroids, and leptin: Observational and interventional studies in humans

Diabetes (New York, N.Y.), 2002-07, Vol.51 (7), p.2105-2112

2002

Volltextzugriff (PDF)

Peptide YY Levels Are Elevated After Gastric Bypass Surgery

Obesity (Silver Spring, Md.), 2006-02, Vol.14 (2), p.194-198

2006

Volltextzugriff (PDF)

Leptin Does Not Mediate Short-Term Fasting-Induced Changes in Growth Hormone Pulsatility but Increases IGF-I in Leptin Deficiency States

The journal of clinical endocrinology and metabolism, 2008-07, Vol.93 (7), p.2819-2827

2008

Volltextzugriff (PDF)

Ghrelin Levels Are Not Regulated by Recombinant Leptin Administration and/or Three Days of Fasting in Healthy Subjects

The journal of clinical endocrinology and metabolism, 2004-01, Vol.89 (1), p.335-343

2004

Volltextzugriff (PDF)

1 – 25 von 681

Suche als RSS-Feed

Aktive Filter

KollektionScienceDirect Journals (5 years ago - present)

Zeitschrift / SerieHepatology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(594)
Mit Volltextzugriff
(542)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(456)
Life Sciences & Biomedicine
(382)
Humans
(360)
Male
(222)
Female
(209)
Middle Aged
(127)
Adult
(122)
Biological And Medical Sciences
(118)
Aged
(107)
Medical Sciences
(99)
Animals
(73)
General & Internal Medicine
(57)
Risk Factors
(56)
Adolescent
(47)
Endocrinology & Metabolism
(47)
Life Sciences
(45)
Oncology
(45)
Medicine, General & Internal
(44)
Mice
(43)
Science & Technology - Other Topics
(43)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(9)

Menü

Weitere Dienste

Einstellungen

Management of the Metabolic Syndrome and Type 2 Diabetes Through Lifestyle Modification

The role of falling leptin levels in the neuroendocrine and metabolic adaptation to short-term starvation in healthy men

Noninvasive predictors of clinically significant portal hypertension in NASH cirrhosis: Validation of ANTICIPATE models and development of a lab‐based model

The clinical approach to the detection of lipodystrophy - an AACE consensus statement

Differential regulation of metabolic, neuroendocrine, and immune function by leptin in humans

Randomised clinical trial: emricasan versus placebo significantly decreases ALT and caspase 3/7 activation in subjects with non‐alcoholic fatty liver disease

Clinical effects of long-term metreleptin treatment in patients with lipodystrophy

Crinecerfont Lowers Elevated Hormone Markers in Adults With 21-Hydroxylase Deficiency Congenital Adrenal Hyperplasia

Crinecerfont, a CRF1 Receptor Antagonist, Lowers Adrenal Androgens in Adolescents With Congenital Adrenal Hyperplasia

Immunogenicity associated with metreleptin treatment in patients with obesity or lipodystrophy

Recombinant Human Leptin in Women with Hypothalamic Amenorrhea

Phase 3 Trial of Crinecerfont in Adult Congenital Adrenal Hyperplasia

Phase 3 Trial of Crinecerfont in Pediatric Congenital Adrenal Hyperplasia

Multicenter, Double‐Blind, Randomized Trial of Emricasan in Hepatitis C–Treated Liver Transplant Recipients With Residual Fibrosis or Cirrhosis

Circulating Resistin Levels Are Not Associated with Obesity or Insulin Resistance in Humans and Are Not Regulated by Fasting or Leptin Administration: Cross-Sectional and Interventional Studies in Normal, Insulin-Resistant, and Diabetic Subjects

Serum Adiponectin Levels Are Inversely Associated with Overall and Central Fat Distribution but Are Not Directly Regulated by Acute Fasting or Leptin Administration in Humans: Cross-Sectional and Interventional Studies

Recombinant Methionyl Human Leptin Therapy in Replacement Doses Improves Insulin Resistance and Metabolic Profile in Patients with Lipoatrophy and Metabolic Syndrome Induced by the Highly Active Antiretroviral Therapy

Lymphoma in acquired generalized lipodystrophy

Clinical classification and treatment of congenital and acquired lipodystrophy

Diurnal and Ultradian Dynamics of Serum Adiponectin in Healthy Men: Comparison with Leptin, Circulating Soluble Leptin Receptor, and Cortisol Patterns

Rationale for leptin-replacement therapy for severe lipodystrophy

Regulation of circulating soluble leptin receptor levels by gender, adiposity, sex steroids, and leptin: Observational and interventional studies in humans

Peptide YY Levels Are Elevated After Gastric Bypass Surgery

Leptin Does Not Mediate Short-Term Fasting-Induced Changes in Growth Hormone Pulsatility but Increases IGF-I in Leptin Deficiency States

Ghrelin Levels Are Not Regulated by Recombinant Leptin Administration and/or Three Days of Fasting in Healthy Subjects

Aktive Filter

Suchergebnisse filtern